Sinclair Pharma, a global aesthetics company, agreed to acquire Viora, a global company in the medical aesthetic market. Financial terms were not disclosed. "This acquisition is an affirmation of Viora’s success in the aesthetic medical device market in the US. Its unique concept enables customers full flexibility and control on their technology growth, together with a one-of-a-kind practice development support. These exceptional assets are a result of the many years of hard work of our skillful and dedicated employees all over the world. We are confident that the values and culture Viora shares with Cocoon, will create a new powerhouse in the aesthetic industry,” Eliran Almog, Viora CEO.